Table 3.
Outcomes (versus recovery as reference) | Relapsing rheumatic musculoskeletal pain | Lingering rheumatic musculoskeletal pain | ||||
---|---|---|---|---|---|---|
Determinants | Adjusted OR | 95% CI | P-value | Adjusted OR | 95% CI | P-value |
Gender | ||||||
Male | 1 | 1 | ||||
Female | 0.92 | 0.44, 1.92 | 0.831 | 1.03 | 0.45, 2.31 | 0.951 |
Age | ||||||
15 to 29 yrs | 1 | 1 | ||||
30 to 44 yrs | 2.08 | 0.81, 5.32 | 0.124 | 2.29 | 0.74, 6.99 | 0.146 |
45 to 59 yrs | 2.93 | 1.00, 8.57 | 0.049 | 6.35 | 1.82, 22.10 | 0.004 |
≥ 60 yrs | 10.44 | 3.50, 31.10 | < 0.001 | 22.30 | 6.36, 78.06 | < 0.001 |
Initial rheumatic involvement | ||||||
Low to moderate† | 1 | 1 | ||||
Severe‡ | 3.60 | 1.58, 8.21 | 0.002 | 5.52 | 2.20, 13.81 | < 0.001 |
CHIKV-specific IgG titre (per one unit increase) | 3.16 | 1.82, 5.48 | < 0.001 | 6.16 | 2.88, 13.20 | < 0.001 |
OR, odds ratio; CHIKV, Chikungunya virus. All estimations and P-values are weighted by the sampling scheme. All subjects had joint or muscle pain at disease onset. †Joint or muscle pain with at most two of the three following conditions: fever, six or more localisations of arthralgias, or at least four other symptoms; ‡fever and six or more localizations of arthralgias and at least four other symptoms.